A detailed history of Franklin Resources Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Franklin Resources Inc holds 69,382 shares of CSTL stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,382
Previous 69,382 -0.0%
Holding current value
$2.06 Million
Previous $1.98 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.4 - $31.47 $562,785 - $1.02 Million
32,344 Added 87.33%
69,382 $1.98 Million
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $28,975 - $38,357
1,538 Added 4.33%
37,038 $806,000
Q1 2024

May 13, 2024

BUY
$18.06 - $25.3 $641,130 - $898,150
35,500 New
35,500 $786,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $779M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.